Linas SL - Search Results

1

Peritoneovenous shunt in the management of the hepatorenal syndrome.

Linas SL, Schaefer JW, Moore EE, Good JT Jr, Giansiracusa R. Linas SL, et al. Kidney Int. 1986 Nov;30(5):736-40. doi: 10.1038/ki.1986.249. Kidney Int. 1986. PMID: 3537462 Free article. Clinical Trial.

2

Alpha-melanocyte-stimulating hormone inhibits renal injury in the absence of neutrophils.

Chiao H, Kohda Y, McLeroy P, Craig L, Linas S, Star RA. Chiao H, et al. Kidney Int. 1998 Sep;54(3):765-74. doi: 10.1046/j.1523-1755.1998.00075.x. Kidney Int. 1998. PMID: 9734601 Free article.

3

Continuous Renal Replacement Therapy Dosing in the Severely Underweight: A Case Report.

Griffin BR, Ambruso S, Jovanovich A, Bansal A, Linas S, Dylewski J. Griffin BR, et al. Kidney Med. 2019 Jun 17;1(4):217-220. doi: 10.1016/j.xkme.2019.04.007. eCollection 2019 Jul-Aug. Kidney Med. 2019. PMID: 32734202 Free PMC article.

4

Training the next generation's nephrology workforce.

Berns JS, Ellison DH, Linas SL, Rosner MH. Berns JS, et al. Among authors: linas sl. Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1639-44. doi: 10.2215/CJN.00560114. Epub 2014 Jun 26. Clin J Am Soc Nephrol. 2014. PMID: 24970877 Free PMC article.

5

Critical and honest conversations: the evidence behind the "Choosing Wisely" campaign recommendations by the American Society of Nephrology.

Williams AW, Dwyer AC, Eddy AA, Fink JC, Jaber BL, Linas SL, Michael B, O'Hare AM, Schaefer HM, Shaffer RN, Trachtman H, Weiner DE, Falk AR; American Society of Nephrology Quality, and Patient Safety Task Force. Williams AW, et al. Among authors: linas sl. Clin J Am Soc Nephrol. 2012 Oct;7(10):1664-72. doi: 10.2215/CJN.04970512. Epub 2012 Sep 13. Clin J Am Soc Nephrol. 2012. PMID: 22977214

6

A behavioral and systems view of professionalism.

Lesser CS, Lucey CR, Egener B, Braddock CH 3rd, Linas SL, Levinson W. Lesser CS, et al. Among authors: linas sl. JAMA. 2010 Dec 22;304(24):2732-7. doi: 10.1001/jama.2010.1864. JAMA. 2010. PMID: 21177508

7

Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension.

Hanratty R, Chonchol M, Miriam Dickinson L, Beaty BL, Estacio RO, Mackenzie TD, Hurley LP, Linas SL, Steiner JF, Havranek EP. Hanratty R, et al. Among authors: linas sl. Nephrol Dial Transplant. 2010 Mar;25(3):801-7. doi: 10.1093/ndt/gfp534. Epub 2009 Nov 4. Nephrol Dial Transplant. 2010. PMID: 19889870 Free PMC article.

8

Managing CKD: key therapeutic issues introduction.

Linas SL. Linas SL. Clin J Am Soc Nephrol. 2008 Jan;3 Suppl 1(Suppl 1):S1-2. doi: 10.2215/CJN.03240807. Clin J Am Soc Nephrol. 2008. PMID: 18178790 Free PMC article. No abstract available.

9

Are two better than one? Angiotensin-converting enzyme inhibitors plus angiotensin receptor blockers for reducing blood pressure and proteinuria in kidney disease.

Linas SL. Linas SL. Clin J Am Soc Nephrol. 2008 Jan;3 Suppl 1(Suppl 1):S17-23. doi: 10.2215/CJN.03270807. Clin J Am Soc Nephrol. 2008. PMID: 18178792 Free PMC article. Review.

10

Predicting, preparing for, and creating the future: what will happen to internal medicine?

Hemmer PA, Costa ST, DeMarco DM, Linas SL, Glazier DC, Schuster BL. Hemmer PA, et al. Among authors: linas sl. Am J Med. 2007 Dec;120(12):1091-6. doi: 10.1016/j.amjmed.2007.09.013. Am J Med. 2007. PMID: 18060932 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page